MBX Biosciences Submits IND for Once-Monthly Obesity Drug
MBX Biosciences Inc. (NASDAQ:MBX) is one of the best IPO stocks to buy according to Wall Street analysts.
Mbx Biosciences Inc. (MBX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 4,002,887 | $70,050,523 | 1.65% | |
| 2. | Deep Track Capital David Kroin | 3,150,000 | $55,125,000 | +44% | 1.54% |
| 3. | EcoR1 Capital Oleg Nodelman | 2,123,604 | $37,163,070 | +85% | 1.78% |
| 4. | Kynam Capital Derrick Tang | 2,000,000 | $35,000,000 | 2.61% | |
| 5. | Driehaus Capital Richard Driehaus | 1,539,639 | $26,943,683 | -3% | 0.19% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.64 | 20,000 | $272,790.00 | 468,277 | 2025-10-20 | Filing | |
| $13.25 | 20,000 | $264,984.00 | 20,000 | 2025-10-17 | Filing | |
| $18.00 | 666,666 | $11,999,988.00 | 5,219,440 | 2025-09-26 | Filing | |
| $5.89 | 7,693 | $45,311.77 | 24,329 | 2025-04-08 | Filing | |
| $10.84 | 94,100 | $1,020,044.00 | 747,887 | 2025-02-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,652,013 | $116,410,228 | 3.49% | |
| 2. | 4,823,336 | $84,408,382 | 0.01% | |
| 3. | 3,614,486 | $63,253,505 | 3.47% | |
| 4. | 2,136,335 | $37,385,863 | 22.51% | |
| 5. | 1,957,461 | $34,255,569 | 0% |
News See All
13 Best IPO Stocks to Buy According to Wall Street Analysts
On August 14, Tony Kim, Centerview Partners co-president, joined CNBC's 'Closing Bell: Overtime' to discuss the IPO market and the dealmaking environment.
Hedge Fund Resource Center Billionaire Hedge Funds
